Effectiveness of Cetuximab/Gefitinib in the Therapy of a Sacral Chordoma

Publisher： Karger

E-ISSN： 2296-5262|29|12|572-574

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.12, 2006-12, pp. : 572-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic factors in surgical resection of sacral chordoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 4, 2015-08 ,pp. : 344-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic factors in surgical resection of sacral chordoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 22-4790, Iss. 4, 2015-08 ,pp. : 344-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multidisciplinary approach of lumbo‐sacral chordoma: From oncological treatment to reconstructive surgery

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 5, 2015-12 ,pp. : 544-554

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Rare Cause of Cauda Equina Syndrome by Infiltration: Case of a Sacral Chordoma

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 6, 2015-06 ,pp. : 1269-1270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of KRAS Testing and Cetuximab as Last-Line Therapy for Colorectal Cancer

By Shiroiwa Takeru   Motoo Yoshiharu  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 6, 2010-12 ,pp. : 375-384

Adis International

Access to resources Recommend Favorite